Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2001 1
2002 1
2003 1
2004 3
2005 3
2006 1
2007 1
2008 2
2009 6
2010 3
2011 6
2013 1
2014 3
2015 2
2016 2
2017 2
2018 1
2019 3
2020 4
2021 4
2022 6
2023 2
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.
Goodall RL, Meredith SK, Nunn AJ, Bayissa A, Bhatnagar AK, Bronson G, Chiang CY, Conradie F, Gurumurthy M, Kirenga B, Kiria N, Meressa D, Moodliar R, Narendran G, Ngubane N, Rassool M, Sanders K, Solanki R, Squire SB, Torrea G, Tsogt B, Tudor E, Van Deun A, Rusen ID; STREAM study collaborators. Goodall RL, et al. Among authors: rusen id. Lancet. 2022 Nov 26;400(10366):1858-1868. doi: 10.1016/S0140-6736(22)02078-5. Epub 2022 Nov 8. Lancet. 2022. PMID: 36368336 Free PMC article. Clinical Trial.
Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trial.
Goodall RL, Nunn AJ, Meredith SK, Bayissa A, Bhatnagar AK, Chiang CY, Conradie F, Gopalan N, Gurumurthy M, Kirenga B, Kiria N, Meressa D, Moodliar R, Ngubane N, Rassool M, Sanders K, Solanki R, Squire SB, Teferi M, Torrea G, Tsogt B, Tudor E, Van Deun A, Rusen ID; STREAM study collaborators. Goodall RL, et al. Among authors: rusen id. Lancet Respir Med. 2024 Dec;12(12):975-987. doi: 10.1016/S2213-2600(24)00186-3. Epub 2024 Oct 1. Lancet Respir Med. 2024. PMID: 39366400 Free article. Clinical Trial.
Protecting those who care for others.
Rusen ID. Rusen ID. Public Health Action. 2017 Dec 21;7(4):244. doi: 10.5588/pha.17.0110. Public Health Action. 2017. PMID: 29344441 Free PMC article. No abstract available.
QT prolongation in the STREAM Stage 1 Trial.
Hughes G, Bern H, Chiang CY, Goodall RL, Nunn AJ, Rusen ID, Meredith SK. Hughes G, et al. Among authors: rusen id. Int J Tuberc Lung Dis. 2022 Apr 1;26(4):334-340. doi: 10.5588/ijtld.21.0403. Int J Tuberc Lung Dis. 2022. PMID: 35351238 Free PMC article. Clinical Trial.
Tuberculosis State of the Art series.
Rusen ID. Rusen ID. Int J Tuberc Lung Dis. 2008 Nov;12(11):1223. Int J Tuberc Lung Dis. 2008. PMID: 18926030 No abstract available.
60 results